カテゴリー： QYResearch, 世界

B細胞リンパ腫2阻害剤の世界市場：規模・現状・予測2019-2025

【英語タイトル】Global B-cell lymphoma 2 Inhibitors Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料（DATA909X18212）・商品コード：DATA909X18212
・発行会社（調査会社）：QYResearch
・発行日：2019年11月25日（※2025年版があります。お問い合わせください）
・ページ数：95
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥585,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥877,500見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥1,170,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※当調査レポートでは、B細胞リンパ腫2阻害剤の世界市場について調査・分析し、B細胞リンパ腫2阻害剤の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（併用療法、単剤療法）、用途別（慢性リンパ性白血病、小リンパ球性リンパ腫、急性骨髄性白血病）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界のB細胞リンパ腫2阻害剤市場動向
・主要企業別マーケットシェア
・B細胞リンパ腫2阻害剤の種類別市場規模2014-2019
（併用療法、単剤療法）
・B細胞リンパ腫2阻害剤の用途別市場規模2014-2019
（慢性リンパ性白血病、小リンパ球性リンパ腫、急性骨髄性白血病）
・B細胞リンパ腫2阻害剤の北米市場：主要企業・種類別/用途別市場規模
・B細胞リンパ腫2阻害剤のヨーロッパ市場：主要企業・種類別/用途別市場規模
・B細胞リンパ腫2阻害剤の中国市場：主要企業・種類別/用途別市場規模
・B細胞リンパ腫2阻害剤の日本国内市場：主要企業・種類別/用途別市場規模
・B細胞リンパ腫2阻害剤の東南アジア市場：主要企業・種類別/用途別市場規模
・B細胞リンパ腫2阻害剤のインド市場：主要企業・種類別/用途別市場規模
・B細胞リンパ腫2阻害剤の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（AbbVie Inc.、F. Hoffmann-La Roche Ltd.、Santa Cruz Biotechnology、Tocris、Biovision）
・B細胞リンパ腫2阻害剤の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...
【レポートの概要】

Bcl-2 (B-cell lymphoma 2), encoded in humans by the BCL2 gene, is the founding member of the Bcl-2 family of regulator proteins that regulate cell death (apoptosis), by either inhibiting (anti-apoptotic) or inducing (pro-apoptotic) apoptosis.The symptoms of hematological malignancies are often mild or not apparent, which delays diagnosis and treatment. To overcome this challenge, many organizations such as KNOW AML group and market vendors have been organizing awareness campaigns, which educate patients about the symptoms and available diagnostic methods and treatment options. This factor has increased the sales of various therapeutics, including BCL-2 inhibitors, which is a crucial drug for treating indications such as chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and acute myeloid leukemia (AML). The awareness programs also conduct cancer screening and encourage people to become blood stem cell donors. This will provide significant growth opportunities to market vendors.
In 2018, the global B-cell lymphoma 2 Inhibitors market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global B-cell lymphoma 2 Inhibitors status, future forecast, growth opportunity, key market and key players. The study objectives are to present the B-cell lymphoma 2 Inhibitors development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
AbbVie Inc.
F. Hoffmann-La Roche Ltd.
Santa Cruz Biotechnology
Tocris
Biovision
…

Market segment by Type, the product can be split into
Combination Therapy
Monotherapy

Market segment by Application, split into
Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma
Cute Myeloid Leukemia

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global B-cell lymphoma 2 Inhibitors status, future forecast, growth opportunity, key market and key players.
To present the B-cell lymphoma 2 Inhibitors development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of B-cell lymphoma 2 Inhibitors are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global B-cell lymphoma 2 Inhibitors Market Size Growth Rate by Type (2014-2025)
1.4.2 Combination Therapy
1.4.3 Monotherapy
1.5 Market by Application
1.5.1 Global B-cell lymphoma 2 Inhibitors Market Share by Application (2019-2025)
1.5.2 Chronic Lymphocytic Leukemia
1.5.3 Small Lymphocytic Lymphoma
1.5.4 Cute Myeloid Leukemia
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 B-cell lymphoma 2 Inhibitors Market Size
2.2 B-cell lymphoma 2 Inhibitors Growth Trends by Regions
2.2.1 B-cell lymphoma 2 Inhibitors Market Size by Regions (2019-2025)
2.2.2 B-cell lymphoma 2 Inhibitors Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 B-cell lymphoma 2 Inhibitors Market Size by by Players
3.1.1 Global B-cell lymphoma 2 Inhibitors Revenue by by Players (2014-2019)
3.1.2 Global B-cell lymphoma 2 Inhibitors Revenue Market Share by by Players (2014-2019)
3.1.3 Global B-cell lymphoma 2 Inhibitors Market Concentration Ratio (CR5 and HHI)
3.2 B-cell lymphoma 2 Inhibitors Key Players Head office and Area Served
3.3 Key Players B-cell lymphoma 2 Inhibitors Product/Solution/Service
3.4 Date of Enter into B-cell lymphoma 2 Inhibitors Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global B-cell lymphoma 2 Inhibitors Market Size by Type (2014-2019)
4.2 Global B-cell lymphoma 2 Inhibitors Market Size by Application (2014-2019)

5 North America
5.1 North America B-cell lymphoma 2 Inhibitors Market Size (2014-2019)
5.2 B-cell lymphoma 2 Inhibitors Key Players in North America
5.3 North America B-cell lymphoma 2 Inhibitors Market Size by Type
5.4 North America B-cell lymphoma 2 Inhibitors Market Size by Application

6 Europe
6.1 Europe B-cell lymphoma 2 Inhibitors Market Size (2014-2019)
6.2 B-cell lymphoma 2 Inhibitors Key Players in Europe
6.3 Europe B-cell lymphoma 2 Inhibitors Market Size by Type
6.4 Europe B-cell lymphoma 2 Inhibitors Market Size by Application

7 China
7.1 China B-cell lymphoma 2 Inhibitors Market Size (2014-2019)
7.2 B-cell lymphoma 2 Inhibitors Key Players in China
7.3 China B-cell lymphoma 2 Inhibitors Market Size by Type
7.4 China B-cell lymphoma 2 Inhibitors Market Size by Application

8 Japan
8.1 Japan B-cell lymphoma 2 Inhibitors Market Size (2014-2019)
8.2 B-cell lymphoma 2 Inhibitors Key Players in Japan
8.3 Japan B-cell lymphoma 2 Inhibitors Market Size by Type
8.4 Japan B-cell lymphoma 2 Inhibitors Market Size by Application

9 Southeast Asia
9.1 Southeast Asia B-cell lymphoma 2 Inhibitors Market Size (2014-2019)
9.2 B-cell lymphoma 2 Inhibitors Key Players in Southeast Asia
9.3 Southeast Asia B-cell lymphoma 2 Inhibitors Market Size by Type
9.4 Southeast Asia B-cell lymphoma 2 Inhibitors Market Size by Application

10 India
10.1 India B-cell lymphoma 2 Inhibitors Market Size (2014-2019)
10.2 B-cell lymphoma 2 Inhibitors Key Players in India
10.3 India B-cell lymphoma 2 Inhibitors Market Size by Type
10.4 India B-cell lymphoma 2 Inhibitors Market Size by Application

11 Central & South America
11.1 Central & South America B-cell lymphoma 2 Inhibitors Market Size (2014-2019)
11.2 B-cell lymphoma 2 Inhibitors Key Players in Central & South America
11.3 Central & South America B-cell lymphoma 2 Inhibitors Market Size by Type
11.4 Central & South America B-cell lymphoma 2 Inhibitors Market Size by Application

12 International Players Profiles
12.1 AbbVie Inc.
12.1.1 AbbVie Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 B-cell lymphoma 2 Inhibitors Introduction
12.1.4 AbbVie Inc. Revenue in B-cell lymphoma 2 Inhibitors Business (2014-2019))
12.1.5 AbbVie Inc. Recent Development
12.2 F. Hoffmann-La Roche Ltd.
12.2.1 F. Hoffmann-La Roche Ltd. Company Details
12.2.2 Company Description and Business Overview
12.2.3 B-cell lymphoma 2 Inhibitors Introduction
12.2.4 F. Hoffmann-La Roche Ltd. Revenue in B-cell lymphoma 2 Inhibitors Business (2014-2019)
12.2.5 F. Hoffmann-La Roche Ltd. Recent Development
12.3 Santa Cruz Biotechnology
12.3.1 Santa Cruz Biotechnology Company Details
12.3.2 Company Description and Business Overview
12.3.3 B-cell lymphoma 2 Inhibitors Introduction
12.3.4 Santa Cruz Biotechnology Revenue in B-cell lymphoma 2 Inhibitors Business (2014-2019)
12.3.5 Santa Cruz Biotechnology Recent Development
12.4 Tocris
12.4.1 Tocris Company Details
12.4.2 Company Description and Business Overview
12.4.3 B-cell lymphoma 2 Inhibitors Introduction
12.4.4 Tocris Revenue in B-cell lymphoma 2 Inhibitors Business (2014-2019)
12.4.5 Tocris Recent Development
12.5 Biovision
12.5.1 Biovision Company Details
12.5.2 Company Description and Business Overview
12.5.3 B-cell lymphoma 2 Inhibitors Introduction
12.5.4 Biovision Revenue in B-cell lymphoma 2 Inhibitors Business (2014-2019)
12.5.5 Biovision Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table B-cell lymphoma 2 Inhibitors Key Market Segments
Table Key Players B-cell lymphoma 2 Inhibitors Covered
Table Global B-cell lymphoma 2 Inhibitors Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Combination Therapy Figures
Table Key Players of Combination Therapy
Figuer Monotherapy Figures
Table Key Players of Monotherapy
Table Global B-cell lymphoma 2 Inhibitors Market Size Growth by Application 2019-2025 (Million US$)
Figure Global B-cell lymphoma 2 Inhibitors Market Share by Application in 2018 & 2025
Figure Chronic Lymphocytic Leukemia Case Studies
Figure Small Lymphocytic Lymphoma Case Studies
Figure Cute Myeloid Leukemia Case Studies
Figure B-cell lymphoma 2 Inhibitors Report Years Considered
Figure Global B-cell lymphoma 2 Inhibitors Market Size and Growth Rate 2014-2025 (Million US$)
Table Global B-cell lymphoma 2 Inhibitors Market Size by Regions 2019-2025 (Million US$)
Table Global B-cell lymphoma 2 Inhibitors Market Size by Regions 2019-2025 (Million US$)
Table Global B-cell lymphoma 2 Inhibitors Market Share by Regions 2014-2019
Figure Global B-cell lymphoma 2 Inhibitors Market Share by Regions 2014-2019
Figure Global B-cell lymphoma 2 Inhibitors Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global B-cell lymphoma 2 Inhibitors Revenue by by Players (2014-2019) (Million US$)
Table Global B-cell lymphoma 2 Inhibitors Market Share by by Players (2014-2019)
Figure Global B-cell lymphoma 2 Inhibitors Market Share by by Players in 2018
Table Global B-cell lymphoma 2 Inhibitors by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players B-cell lymphoma 2 Inhibitors Product/Solution/Service
Table Date of Enter into B-cell lymphoma 2 Inhibitors Market
Table Mergers & Acquisitions, Expansion Plans
Table Global B-cell lymphoma 2 Inhibitors Market Size by Type (2014-2019) (Million US$)
Table Global B-cell lymphoma 2 Inhibitors Market Size Share by Type (2014-2019)
Figure Global B-cell lymphoma 2 Inhibitors Market Size Market Share by Type (2014-2019)
Table Global B-cell lymphoma 2 Inhibitors Market Size by Application (2014-2019) (Million US$)
Table Global B-cell lymphoma 2 Inhibitors Market Size Share by Application (2014-2019)
Figure Global B-cell lymphoma 2 Inhibitors Market Size Market Share by Application (2014-2019)
Figure Global B-cell lymphoma 2 Inhibitors Revenue Market Share by Application in 2018
Figure North America B-cell lymphoma 2 Inhibitors Market Size 2014-2019 (Million US$)
Table North America Key Players B-cell lymphoma 2 Inhibitors Revenue (2018-2019) (Million US$)
Table North America Key Players B-cell lymphoma 2 Inhibitors Market Share (2018-2019)
Table North America B-cell lymphoma 2 Inhibitors Market Size by Type 2014-2019 (Million US$)
Table North America B-cell lymphoma 2 Inhibitors Market Share by Type 2014-2019
Table North America B-cell lymphoma 2 Inhibitors Market Size by Application 2014-2019 (Million US$)
Table North America B-cell lymphoma 2 Inhibitors Market Share by Application 2014-2019
Figure Europe B-cell lymphoma 2 Inhibitors Market Size 2014-2019 (Million US$)
Table Europe Key Players B-cell lymphoma 2 Inhibitors Revenue (2018-2019) (Million US$)
Table Europe Key Players B-cell lymphoma 2 Inhibitors Market Share (2018-2019)
Table Europe B-cell lymphoma 2 Inhibitors Market Size by Type 2014-2019 (Million US$)
Table Europe B-cell lymphoma 2 Inhibitors Market Share by Type 2014-2019
Table Europe B-cell lymphoma 2 Inhibitors Market Size by Application 2014-2019 (Million US$)
Table Europe B-cell lymphoma 2 Inhibitors Market Share by Application 2014-2019
Figure China B-cell lymphoma 2 Inhibitors Market Size 2014-2019 (Million US$)
Table China Key Players B-cell lymphoma 2 Inhibitors Revenue (2018-2019) (Million US$)
Table China Key Players B-cell lymphoma 2 Inhibitors Market Share (2018-2019)
Table China B-cell lymphoma 2 Inhibitors Market Size by Type 2014-2019 (Million US$)
Table China B-cell lymphoma 2 Inhibitors Market Share by Type 2014-2019
Table China B-cell lymphoma 2 Inhibitors Market Size by Application 2014-2019 (Million US$)
Table China B-cell lymphoma 2 Inhibitors Market Share by Application 2014-2019
Figure Japan B-cell lymphoma 2 Inhibitors Market Size 2014-2019 (Million US$)
Table Japan Key Players B-cell lymphoma 2 Inhibitors Revenue (2018-2019) (Million US$)
Table Japan Key Players B-cell lymphoma 2 Inhibitors Market Share (2018-2019)
Table Japan B-cell lymphoma 2 Inhibitors Market Size by Type 2014-2019 (Million US$)
Table Japan B-cell lymphoma 2 Inhibitors Market Share by Type 2014-2019
Table Japan B-cell lymphoma 2 Inhibitors Market Size by Application 2014-2019 (Million US$)
Table Japan B-cell lymphoma 2 Inhibitors Market Share by Application 2014-2019
Figure Southeast Asia B-cell lymphoma 2 Inhibitors Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players B-cell lymphoma 2 Inhibitors Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players B-cell lymphoma 2 Inhibitors Market Share (2018-2019)
Table Southeast Asia B-cell lymphoma 2 Inhibitors Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia B-cell lymphoma 2 Inhibitors Market Share by Type 2014-2019
Table Southeast Asia B-cell lymphoma 2 Inhibitors Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia B-cell lymphoma 2 Inhibitors Market Share by Application 2014-2019
Figure India B-cell lymphoma 2 Inhibitors Market Size 2014-2019 (Million US$)
Table India Key Players B-cell lymphoma 2 Inhibitors Revenue (2018-2019) (Million US$)
Table India Key Players B-cell lymphoma 2 Inhibitors Market Share (2018-2019)
Table India B-cell lymphoma 2 Inhibitors Market Size by Type 2014-2019 (Million US$)
Table India B-cell lymphoma 2 Inhibitors Market Share by Type 2014-2019
Table India B-cell lymphoma 2 Inhibitors Market Size by Application 2014-2019 (Million US$)
Table India B-cell lymphoma 2 Inhibitors Market Share by Application 2014-2019
Figure Central & South America B-cell lymphoma 2 Inhibitors Market Size 2014-2019 (Million US$)
Table Central & South America Key Players B-cell lymphoma 2 Inhibitors Revenue (2018-2019) (Million US$)
Table Central & South America Key Players B-cell lymphoma 2 Inhibitors Market Share (2018-2019)
Table Central & South America B-cell lymphoma 2 Inhibitors Market Size by Type 2014-2019 (Million US$)
Table Central & South America B-cell lymphoma 2 Inhibitors Market Share by Type 2014-2019
Table Central & South America B-cell lymphoma 2 Inhibitors Market Size by Application 2014-2019 (Million US$)
Table Central & South America B-cell lymphoma 2 Inhibitors Market Share by Application 2014-2019
Table AbbVie Inc. Company Details
Table AbbVie Inc. Revenue in B-cell lymphoma 2 Inhibitors Business 2014-2019 (Million US$)
Figure AbbVie Inc. Revenue Growth Rate in B-cell lymphoma 2 Inhibitors Business (2014-2019)
Table AbbVie Inc. Recent Development
Table F. Hoffmann-La Roche Ltd. Company Details
Table F. Hoffmann-La Roche Ltd. Revenue in B-cell lymphoma 2 Inhibitors Business 2014-2019 (Million US$)
Figure F. Hoffmann-La Roche Ltd. Revenue Growth Rate in B-cell lymphoma 2 Inhibitors Business (2014-2019)
Table F. Hoffmann-La Roche Ltd. Recent Development
Table Santa Cruz Biotechnology Company Details
Table Santa Cruz Biotechnology Revenue in B-cell lymphoma 2 Inhibitors Business 2014-2019 (Million US$)
Figure Santa Cruz Biotechnology Revenue Growth Rate in B-cell lymphoma 2 Inhibitors Business (2014-2019)
Table Santa Cruz Biotechnology Recent Development
Table Tocris Company Details
Table Tocris Revenue in B-cell lymphoma 2 Inhibitors Business 2014-2019 (Million US$)
Figure Tocris Revenue Growth Rate in B-cell lymphoma 2 Inhibitors Business (2014-2019)
Table Tocris Recent Development
Table Biovision Company Details
Table Biovision Revenue in B-cell lymphoma 2 Inhibitors Business 2014-2019 (Million US$)
Figure Biovision Revenue Growth Rate in B-cell lymphoma 2 Inhibitors Business (2014-2019)
Table Biovision Recent Development
Table Global B-cell lymphoma 2 Inhibitors Market Size by Regions (Million US$) 2019-2025
Figure Global B-cell lymphoma 2 Inhibitors Market Size Share by Regions (2019-2025)
Figure Global B-cell lymphoma 2 Inhibitors Market Size Share by Regions in 2025
Figure North America B-cell lymphoma 2 Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure Europe B-cell lymphoma 2 Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure China B-cell lymphoma 2 Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure Japan B-cell lymphoma 2 Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia B-cell lymphoma 2 Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure India B-cell lymphoma 2 Inhibitors Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America B-cell lymphoma 2 Inhibitors Market Size Forecast (2019-2025)(Million USD)
Table Global B-cell lymphoma 2 Inhibitors Market Size by Product (2019-2025) (Million US$)
Figure Global B-cell lymphoma 2 Inhibitors Market Size by Product (2019-2025)
Figure Global B-cell lymphoma 2 Inhibitors Market Size by Product in 2025
Table Global B-cell lymphoma 2 Inhibitors Market Size by Application (2019-2025) (Million US$)
Figure Global B-cell lymphoma 2 Inhibitors Market Size by Application (2019-2025)
Figure Global B-cell lymphoma 2 Inhibitors Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

AbbVie Inc.、F. Hoffmann-La Roche Ltd.、Santa Cruz Biotechnology、Tocris、Biovision

★調査レポート[B細胞リンパ腫2阻害剤の世界市場：規模・現状・予測2019-2025] (コード：DATA909X18212)販売に関する免責事項を必ずご確認ください。
★調査レポート[B細胞リンパ腫2阻害剤の世界市場：規模・現状・予測2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • BCL-2（B細胞リンパ腫2）阻害剤の世界市場：規模・現状・予測2019-2025
    DATA909X18213 / QYResearch / 2019年11月25日 / ※当調査レポートでは、BCL-2（B細胞リンパ腫2）阻害剤の世界市場について調査・分析し、BCL-2（B細胞リンパ腫2）阻害剤の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（併用療法、単剤療法）、用途別（陽性リンパ腫、濾胞性リンパ腫、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のBCL-2（B細胞リンパ腫2）阻害剤市場動向 ・主要企業別マーケットシェア ・BCL-2（B細胞リンパ腫2）阻害剤の種類別市場規模2014-2019 （併用療法、単剤療法） ・BCL-2（B細胞リンパ腫2）阻害剤の用途別市場規模2014-2019 （陽性リンパ腫、濾胞性リンパ腫、その他） ・BCL-2（B細胞リンパ腫2）阻害剤の北米市場：主要企業・種類別/用途別市場規模 ・BCL-2（B細胞リンパ腫2）阻害剤のヨーロッパ市場：主要企業・種類別/用途別市場規模...Symptoms of hematologic malignancies are usually mild or inconspicuous, leading to delays in diagnosis and treatment of indications.BCL-2 (B-cell lymphoma 2) inhibitors  regulates the correlation of cell apoptosis at the mitochondrial level, which has the potential to be a therapeutic target for hematologic malignancies.In 2018, the global BCL-2 (B-cell lymphoma 2) Inhibitors market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global BCL-2 (B-cell lymphoma 2) Inhibitors status, future forecast, growth opportunity, key market and key players....
  • マントル細胞リンパ腫治療法の世界市場：規模・現状・予測2019-2025
    DATA909X18670 / QYResearch / 2019年11月25日 / ※当調査レポートでは、マントル細胞リンパ腫治療法の世界市場について調査・分析し、マントル細胞リンパ腫治療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（併用療法、単剤療法）、用途別（病院、研究所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のマントル細胞リンパ腫治療法市場動向 ・主要企業別マーケットシェア ・マントル細胞リンパ腫治療法の種類別市場規模2014-2019 （併用療法、単剤療法） ・マントル細胞リンパ腫治療法の用途別市場規模2014-2019 （病院、研究所、その他） ・マントル細胞リンパ腫治療法の北米市場：主要企業・種類別/用途別市場規模 ・マントル細胞リンパ腫治療法のヨーロッパ市場：主要企業・種類別/用途別市場規模...Mantle cell lymphoma (MCL) is a heterogeneous aggressive disease and remains incurable with current chemotherapies. The development of monoclonal antibody (mAb) has led to substantial achievement in immunotherapeutic strategies for B-cell lymphomas including MCL.Nonetheless, progress in the clinical use of mAbs is hindered by poor efficacy, off-target toxicities and drug resistance. Thus, novel mAbs engineering and approaches to improve target specificity and enhance affinity and potency are required. In 2018, the global Mantle Cell Lymphoma Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of...
  • 選択的セロトニン再取り込み阻害薬（SSRI）の世界市場：規模・現状・予測2019-2025
    DATA909X18951 / QYResearch / 2019年11月25日 / ※当調査レポートでは、選択的セロトニン再取り込み阻害薬（SSRI）の世界市場について調査・分析し、選択的セロトニン再取り込み阻害薬（SSRI）の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（シタロプラム（セレキサ）、エシタロプラム（レキサプロ）、フルオキセチン（プロザック）、パロキセチン（パキシル、ペクセバ）、セルトラリン（ゾロフト）、ビラゾドン（ビブリド））、用途別（うつ病、不安およびパニック障害、その他の精神状態）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の選択的セロトニン再取り込み阻害薬（SSRI）市場動向 ・主要企業別マーケットシェア ・選択的セロトニン再取り込み阻害薬（SSRI）の種類別市場規模2014-2019 （シタロプラム（セレキサ）、エシタロプラム（レキサプロ）、フルオキセチン（プロザック）、パロキセチン（パキシル、ペクセバ）、セルトラリン（ゾロフト）、ビラゾドン（ビブリド）） ・選択的セロトニン再取り込み阻害薬（SSRI）の用途別市場規模2014-2019 （うつ病、不安およびパニック障害、その他の精神状態） ・選択的セロトニン再取り込み阻害薬（SSRI）の北米市場：主要企業・種類別/用途別市場規模 ・選択的セロトニン再取り込み阻害薬（SSRI）のヨーロッパ市場：主要企業・種類別/用途別市場規模...Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed antidepressants. They can ease symptoms of moderate to severe depression, are relatively safe and typically cause fewer side effects than other types of antidepressants do.With an increase in mental illnesses, there is a rising need for effective neurological drugs. Among the various neurological drugs available in the market, SSRIs drugs have high therapeutic efficacy. As a result, the number of vendors manufacturing these drugs is increasing. Moreover, health insurance companies, with support from governments, have started covering treatment expenses related to mental disorder. The rising prevalence of mental illnesses will...

    • ◆H&Iグローバルリサーチのお客様（例）◆